Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro

23 Jul 2021

Abstract excerpt

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is highly contagious and presents a significant public health issue. Current therapies used to treat coronavirus disease 2019 (COVID-19) include monoclonal antibody cocktail, convalescent plasma, antivirals, immunomodulators, and anticoagulants. The vaccines from Pfizer and Moderna have recently been authorized for emergency use, which are invaluable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34367128
DOI: 10.3389/fimmu.2021.652223

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In VitroPMID 34367128Read ↗

CAR-NK Cells Effectively Target the D614 and G614 SARS-CoV-2-infected CellsSemantic proximity Read ↗

Efficacy of Targeting SARS-CoV-2 by CAR-NK CellsSemantic proximity Read ↗

Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipientsSemantic proximity Read ↗

CAR-NK cell therapy: a potential antiviral platformSemantic proximity Read ↗

TLR2/4 are novel activating receptors for SARS-CoV-2 spike protein on NK cellsSemantic proximity Read ↗

ADNKA overcomes SARS-CoV2-mediated NK cell inhibition through non-spike antibodiesSemantic proximity Read ↗

Specific Activation of T Cells by an ACE2-Based CAR-Like Receptor upon Recognition of SARS-CoV-2 Spike ProteinSemantic proximity Read ↗

NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful DevelopmentSemantic proximity Read ↗

Human CD4 + T cells specific for dominant epitopes of SARS-CoV-2 Spike and Nucleocapsid proteins with therapeutic potentialSemantic proximity Read ↗

Dual roles of a novel oncolytic viral vector-based SARS-CoV-2 vaccine: preventing COVID-19 and treating tumor progressionSemantic proximity Read ↗

SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A PathwaySemantic proximity Read ↗

Efficient and Robust NK-Cell Transduction With Baboon Envelope Pseudotyped LentivectorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.